While reports indicate little IL6 production from primary or metastatic clinical prostate cancer samples, the IL6 receptor is present uniformly in a majority of prostate cancers (Siegall et al, 1990; Culig, 2014; Yu et al, 2015). This evidence concerns the gene IL6 and Familial prostate cancer.